Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference in London
Globe Newswire•09/11/2026•16:05 ET
0
Key Highlights
- ➤Corvus to present corporate overview at 2026 Jefferies Global Healthcare Conference
- ➤Presentation scheduled for November 16, 2026 at 2:30 PM GMT
- ➤Soquelitinib in registrational Phase 3 trial for relapsed/refractory PTCL
- ➤Soquelitinib advancing in Phase 2 atopic dermatitis and Phase 1b hidradenitis suppurativa trials
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and present a corporate overview at the 2026 Jefferies Global Healthcare Conference in London. The presentation is scheduled for Monday, November 16, 2026 at 2:30 PM GMT (9:30 am ET / 6:30 am PT).
A webcast of the presentation will be available live and for 90 days following the event. The webcast may be accessed via the investor relations section of the Corvus website.
Get started
Create a free account to read the full story.